Thermo Fisher Scientific Announces "ABgene Plate of the Month”
News Nov 25, 2008
Thermo Fisher Scientific Inc. has announced that it is marking the 2nd century of man-made plastics by providing scientists with valuable ways to trial Thermo Scientific ABgene® PCR and QPCR plates via a Plate of the Month initiative.
The Company explains, When Leo Baekeland invented the world’s first true man-made plastic in 1907, his diary entry stated that he believed that "this invention will prove important in the future." This was definitely an understatement, since man-made plastics have revolutionized life for us all, especially in the field of drug discovery with major advances in PCR and QPCR techniques undertaken using plastic consumables.
‘Our Plate of the Month initiative celebrates not only Baekeland’s achievements, but also those of our own development scientists and manufacturing staff who, over the last 15 years, have contributed by bringing our vast range of high-quality PCR and QPCR plates to the scientific community worldwide –securing our market-leading position,’ according to Thermo Fisher Scientific.
The opening Plate of the Month celebration surrounds the Thermo Scientific low profile ABgene PCR plate (ref AB-0700). The company will give away one case of these low profile PCR plates to the first 10 applicants in November 2008. Subsequent monthly celebrations will focus on other specialist plates within the premium Thermo Scientific ABgene range.
The low profile ABgene® PCR plate has shorter wells than standard PCR plates, making it ideal for use with reaction volumes of less than 20µl. By decreasing the dead space within the well it helps reduce condensation in the well, thus preventing reduction in reaction volume. The plate design incorporates a raised rim around each well for sealing, alphanumeric grid referencing and a cut-away corner for plate orientation.
Integrated Lead Discovery: An Evolving ToolboxNews
A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE